Skip to content
2000
Volume 23, Issue 10
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Due to their unique biological functionality, nanocarriers can be designed to deliver various anti-tumor drugs in vivo, which has a wide and important application prospect in the field of tumor therapy. However, poor biosafety, short blood circulation time, and weak targeting ability still limit the application of nanoparticles in tumor therapy. In recent years, with the development of biomedicine, the biomimetic technology-based biomembrane-mediated drug delivery system is expected to achieve a breakthrough in tumor-targeted therapy due to low immunogenicity, tumor targeting, the adjustability and versatility of intelligent nanocarrier design. This paper mainly reviews the research process of different types of the cell membrane (erythrocyte membrane, cancer cell membrane, bacterial membrane, stem cell membrane, and hybrid membrane)-camouflaged nanoparticles in tumor therapy, as well as the challenges and development prospects in clinical application.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026623666230427114622
2023-04-01
2025-07-13
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026623666230427114622
Loading

  • Article Type:
    Review Article
Keyword(s): Biomedicine; Biomimetic; Cell membrane; Drug delivery; Nanoparticles; Tumor therapy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test